During the past decade, Boehringer Ingelheim conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists
This Study Combines Data From 3 Other Studies Testing Empagliflozin in Patients With Diabetes or With Chronic Heart Failure. The Study Looks at the Numbers of Patients Who Had Lower Limb Amputations
A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin
To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin
2021-12-20
2022-09-12
Completed
72,621
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Boehringer Ingelheim
According to Clinical.Site data, the most researched conditions in "Boehringer Ingelheim" are
"Diabetes Mellitus, Type 2" (3 trials), "Atrial Fibrillation" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Boehringer Ingelheim" in a lesser frequency.
Clinical Trials Intervention Types at Boehringer Ingelheim
Most popular intervention types in "Boehringer Ingelheim" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (2 trials), "DPP-4i" (1 trials), "GLP-1-RA" (1 trials), "Oral non-incretin/non-sodium glucose co-transporter-2 inhibitors (SGLT2)-containing hypoglycaemic agents" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Boehringer Ingelheim
The vast majority of trials in "Boehringer Ingelheim" are
4 trials for "All" genders.
Clinical Trials Status at Boehringer Ingelheim
Currently, there are NaN active trials in "Boehringer Ingelheim".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Boehringer Ingelheim,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Boehringer Ingelheim, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".